ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TH Theratechnologies Inc

2.23
0.25 (12.63%)
Mar 28 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Theratechnologies Inc TH Toronto Common Stock
  Price Change Price Change % Share Price Last Trade
0.25 12.63% 2.23 15:01:05
Open Price Low Price High Price Close Price Previous Close
2.00 2.00 2.24 2.23 1.98
more quote information »

Recent News

Date Time Source Heading
3/28/202406:30GLOBETheratechnologies to Present Preclinical Data at AACR on..
3/22/202408:36GLOBETheratechnologies Announces Update on its Preclinical..
3/21/202419:00GLOBETheratechnologies Appoints Jordan Zwick to its Board of..
3/21/202406:30GLOBETheratechnologies Initiates Increased Dose Level in Phase 1..
2/29/202415:34GLOBETheratechnologies Announces the Resignation of One of Its..
2/27/202406:30GLOBETheratechnologies Receives Refusal to File Letter for..
2/21/202406:30GLOBETheratechnologies Reports Financial Results for the Fourth..
2/20/202406:30GLOBETheratechnologies Announces Publication in Frontiers in..
2/15/202406:30GLOBETheratechnologies Completes Enrollment of First Six Patients..
2/06/202406:30GLOBETheratechnologies to Announce Fourth Quarter and Full Year..
1/24/202409:47DJNTheratechnologies Shares Sink at Open After FDA Rejects..
1/24/202407:52DJNTheratechnologies Shares Slide Premarket as FDA Turns Away..
1/24/202406:49DJNTheratechnologies: FDA Rejects Newer Egrifta Formulation
1/24/202406:00GLOBETheratechnologies Receives Complete Response Letter (CRL)..
1/23/202409:16DJNTheratechnologies Shares Fall as FDA Continues to Review..
1/23/202406:30GLOBETheratechnologies Receives Update from FDA on Tesamorelin F8..
1/02/202408:00APSWill This Dual-Listed Bio-Pharma Catch New Year Action?
1/02/202406:30GLOBETheratechnologies Submits sBLA for Trogarzo® Intramuscular..
12/21/202315:12PRNCATheratechnologies annonce le renouvellement de son..
12/21/202315:09PRNCATheratechnologies Announces Renewal of Shelf Prospectus and..
12/13/202306:30GLOBETheratechnologies Announces FDA Approval of Trogarzo®..
11/24/202306:30GLOBETheratechnologies Receives 2023 CQDM ADRIQ RSRI Innovation..
10/31/202311:34GLOBETheratechnologies Announces Closing of US$25 Million Public..
10/26/202307:00GLOBETheratechnologies Announces Pricing of US$25 Million Public..
10/25/202315:13GLOBETheratechnologies Announces Proposed Public Offering of..
10/24/202306:00GLOBETheratechnologies Announces Operational Update
10/19/202306:30GLOBETheratechnologies’ Ibalizumab Demonstrates..
10/16/202306:30GLOBETheratechnologies Announces Finalization of Amendments to..
10/13/202306:30GLOBETheratechnologies Presents Data at ID Week Showing..
10/13/202306:00GLOBETheratechnologies Announces Results from Trogarzo®..
10/12/202306:30GLOBETheratechnologies Announces Dosing of First Patient in..
10/04/202306:30GLOBETheratechnologies Receives January 2024 PDUFA Goal Date for..
9/26/202306:30GLOBETheratechnologies Reports Financial Results for the Third..
9/25/202306:30GLOBETheratechnologies Announces Agreement in Principle with..
9/25/202306:00GLOBETheratechnologies Submits Tesamorelin F8 Formulation sBLA..
9/20/202306:00GLOBETheratechnologies to Present at the Cantor Fitzgerald Global..
9/18/202315:15GLOBETheratechnologies to Announce Third Quarter 2023 Financial..
9/07/202312:57GLOBETheratechnologies to Present at the H.C. Wainwright 25th..
9/05/202306:00GLOBETheratechnologies Announces Certain Preliminary Q3 2023..
8/30/202309:34GLOBETheratechnologies Announces All U.S. Oncology Clinical Sites..
8/21/202314:24PRNUSToronto Stock Exchange, Theratechnologies Inc., View From..
7/31/202308:00APSBiopharma Firm Completes Reverse Stock Split
7/31/202306:00GLOBETheratechnologies Completes 1-for-4 Reverse Stock Split
7/28/202315:44GLOBETheratechnologies Announces Amendments to its Term Loan..
7/21/202306:00GLOBETheratechnologies Announces the Resignation of One of Its..
7/20/202306:00GLOBETheratechnologies Announces 1-for-4 Reverse Stock Split
7/12/202306:30GLOBETheratechnologies Reports Second Quarter 2023 Financial..
6/29/202306:30GLOBETheratechnologies to Announce Second Quarter 2023 Financial..
6/22/202306:30GLOBETheratechnologies Draws Down on US$20 Million Second Tranche..
6/12/202306:30GLOBETheratechnologies June 13 Oncology Investigator Call to..

Your Recent History

Delayed Upgrade Clock